(Q51575264)

7 April 2018

title

Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus. (English)

1 reference

7 April 2018

author name string

G E Sonnenberg

1

1 reference

7 April 2018

D C Garg

2

1 reference

7 April 2018

D J Weidler

3

1 reference

7 April 2018

R M Dixon

4

1 reference

7 April 2018

L A Jaber

5

1 reference

7 April 2018

A J Bowen

6

1 reference

7 April 2018

G S DeChemey

7

1 reference

7 April 2018

W S Mullican

8

1 reference

7 April 2018

L D Stonesifer

9

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

7 April 2018

Annals of Pharmacotherapy

published in

1 reference

7 April 2018

volume

31

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

671-676

1 reference

7 April 2018

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

How often is medication taken as prescribed? A novel assessment technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Radioimmunological determination of human C-peptide in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Determination of free and total insulin and C-peptide in insulin-treated diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Role of patient compliance in clinical pharmacokinetics. A review of recent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

Clinical profile of glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100601

10.1177/106002809703100601

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

release_uhz2dqzcsndwniwqnopmuyyfqq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uhz2dqzcsndwniwqnopmuyyfqq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9184703

1 reference

7 April 2018